The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
Pharmaceutical Technology Europe
Process analysers have evolved from basic analogue devices with adjustable potentiometers, analogue current outputs and alarm relays into smart, powerful, two-way digital transmitters with advanced features, such as automatic calibration and self-diagnostics, that can transmit more information, more accurately. This article will discuss advances in process analytical devices and how they can be applied to both new and existing pharmaceutical facilities.
ePT--the Electronic Newsletter of Pharmaceutical Technology
Microbioreactor Array System Boost Cell Culture Capacity
ePT--the Electronic Newsletter of Pharmaceutical Technology
Teva Absorbs Ivax In $7.4 Billion Bid
ePT--the Electronic Newsletter of Pharmaceutical Technology
Protein Refolding Technology Improves Yields
Aptuit To Purchase Quintiles
Able Labs Files for Chapter 11
Xanodyne Acquires aaiPharma Assets
Chiron Cuts Supply of Flu Vaccines Made in Germany; Liverpool Plant Under Inspection
Able Interim Chief Resigns Amid Drug Recall
First Contraceptive Spray Offers Advantages over the Pill
Q Chip Develops Fully Functioning MicroPlant
A stepwise, process risk-assessment approach can facilitate the identification and understanding of critical process parameters, quality attributes, and in-process controls. This approach can lead to more use of science- and risk-based regulatory practices to simplify the regulatory requirements for changes to synthetic processes and to support the underlying quality systems that ensure compliance.
Singapore is competing aggressively with India and China for a piece of the Asian sourcing business.
Can macromolecular processes learn from small-molecule experience? Burdened by exploding bioreactor productivity, architects of downstream bioseparation technology are looking into the drug industry's past for inspiration, while small-molecule companies adopt techniques pioneered by biotechnology. (The first of three articles on the current state of separations.)
Genentech Anticipates Full-Capacity Manufacturing
Schering AG To Cut Plants and Staff
Molding Technique Improves Nanoparticle Production
Warning Letter: Pragmatic Materials
FDA Posts Q5E Biotech and Biological Products Comparability Guideline
Blister Packaging Trumps Bottles For Patient Compliance, Study Shows
Wyeth and Purdue Announce Restructuring Plans
Development Collaboration for Ophthalmic Drugs Could Eliminate Injections
Warning letter: C&M Oxyfill
